Want to join the conversation?
$JCI 3Q15 Call: Building Efficiency revenues were up 10% without FX. North America was up about 4%. Middle East was up 18%. Europe was down about 1%. Latin America was down 10%. Orders were up 9%. Excluding FX and ADT, underlying orders were up 6%. Backlog was up 5% at $4.7Bil, adjusting for FX. Segment income was $272MM, up 3%.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.